Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Account Payables (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Change in Account Payables for 12 consecutive years, with $310000.0 as the latest value for Q1 2026.

  • For Q1 2026, Change in Account Payables fell 82.96% year-over-year to $310000.0; the TTM value through Mar 2026 reached -$443000.0, up 6.74%, while the annual FY2025 figure was $1.1 million, 136.42% up from the prior year.
  • Change in Account Payables hit $310000.0 in Q1 2026 for Cartesian Therapeutics, up from -$933000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $2.8 million in Q4 2023 and bottomed at -$2.4 million in Q3 2024.
  • Average Change in Account Payables over 5 years is $80882.4, with a median of $85000.0 recorded in 2023.
  • Year-over-year, Change in Account Payables skyrocketed 4050.0% in 2023 and then plummeted 2923.53% in 2024.
  • Cartesian Therapeutics' Change in Account Payables stood at $102000.0 in 2022, then soared by 2643.14% to $2.8 million in 2023, then tumbled by 108.47% to -$237000.0 in 2024, then crashed by 293.67% to -$933000.0 in 2025, then surged by 133.23% to $310000.0 in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at $310000.0, -$933000.0, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.